The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Continuous Glucose Monitoring (CGM) Market Research Report 2025
Synopsis
A continuous glucose monitoring (CGM) system may help in these cases. The system consists of a small disposable sensor inserted into the skin, a transmitter connected to the sensor by a sensor mount wirelessly transmits results to a receiver and displays results.
The global Continuous Glucose Monitoring (CGM) market was valued at US$ 4612 million in 2023 and is anticipated to reach US$ 5979.4 million by 2030, witnessing a CAGR of 3.7% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Continuous Glucose Monitoring (CGM), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Continuous Glucose Monitoring (CGM).
Report Scope
The Continuous Glucose Monitoring (CGM) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Continuous Glucose Monitoring (CGM) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Continuous Glucose Monitoring (CGM) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Baxter
Abbott Laboratories
Medtronic
Animas
Novo Nordisk
Ypsomed
GlySens
Segment by Type
Transmitters
Sensors
Insulin Pumps
Segment by Application
Hospitals
Homecare Settings
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Continuous Glucose Monitoring (CGM) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Continuous Glucose Monitoring (CGM) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
A continuous glucose monitoring (CGM) system may help in these cases. The system consists of a small disposable sensor inserted into the skin, a transmitter connected to the sensor by a sensor mount wirelessly transmits results to a receiver and displays results.
The global Continuous Glucose Monitoring (CGM) market was valued at US$ 4612 million in 2023 and is anticipated to reach US$ 5979.4 million by 2030, witnessing a CAGR of 3.7% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Continuous Glucose Monitoring (CGM), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Continuous Glucose Monitoring (CGM).
Report Scope
The Continuous Glucose Monitoring (CGM) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Continuous Glucose Monitoring (CGM) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Continuous Glucose Monitoring (CGM) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Baxter
Abbott Laboratories
Medtronic
Animas
Novo Nordisk
Ypsomed
GlySens
Segment by Type
Transmitters
Sensors
Insulin Pumps
Segment by Application
Hospitals
Homecare Settings
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Continuous Glucose Monitoring (CGM) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Continuous Glucose Monitoring (CGM) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Continuous Glucose Monitoring (CGM) Market Overview
1.1 Product Overview and Scope of Continuous Glucose Monitoring (CGM)
1.2 Continuous Glucose Monitoring (CGM) Segment by Type
1.2.1 Global Continuous Glucose Monitoring (CGM) Market Value Comparison by Type (2024-2030)
1.2.2 Transmitters
1.2.3 Sensors
1.2.4 Insulin Pumps
1.3 Continuous Glucose Monitoring (CGM) Segment by Application
1.3.1 Global Continuous Glucose Monitoring (CGM) Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Homecare Settings
1.3.4 Others
1.4 Global Continuous Glucose Monitoring (CGM) Market Size Estimates and Forecasts
1.4.1 Global Continuous Glucose Monitoring (CGM) Revenue 2019-2030
1.4.2 Global Continuous Glucose Monitoring (CGM) Sales 2019-2030
1.4.3 Global Continuous Glucose Monitoring (CGM) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Continuous Glucose Monitoring (CGM) Market Competition by Manufacturers
2.1 Global Continuous Glucose Monitoring (CGM) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Continuous Glucose Monitoring (CGM) Average Price by Manufacturers (2019-2024)
2.4 Global Continuous Glucose Monitoring (CGM) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Continuous Glucose Monitoring (CGM), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Continuous Glucose Monitoring (CGM), Product Type & Application
2.7 Continuous Glucose Monitoring (CGM) Market Competitive Situation and Trends
2.7.1 Continuous Glucose Monitoring (CGM) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Continuous Glucose Monitoring (CGM) Players Market Share by Revenue
2.7.3 Global Continuous Glucose Monitoring (CGM) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Continuous Glucose Monitoring (CGM) Retrospective Market Scenario by Region
3.1 Global Continuous Glucose Monitoring (CGM) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Continuous Glucose Monitoring (CGM) Global Continuous Glucose Monitoring (CGM) Sales by Region: 2019-2030
3.2.1 Global Continuous Glucose Monitoring (CGM) Sales by Region: 2019-2024
3.2.2 Global Continuous Glucose Monitoring (CGM) Sales by Region: 2025-2030
3.3 Global Continuous Glucose Monitoring (CGM) Global Continuous Glucose Monitoring (CGM) Revenue by Region: 2019-2030
3.3.1 Global Continuous Glucose Monitoring (CGM) Revenue by Region: 2019-2024
3.3.2 Global Continuous Glucose Monitoring (CGM) Revenue by Region: 2025-2030
3.4 North America Continuous Glucose Monitoring (CGM) Market Facts & Figures by Country
3.4.1 North America Continuous Glucose Monitoring (CGM) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Continuous Glucose Monitoring (CGM) Sales by Country (2019-2030)
3.4.3 North America Continuous Glucose Monitoring (CGM) Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Continuous Glucose Monitoring (CGM) Market Facts & Figures by Country
3.5.1 Europe Continuous Glucose Monitoring (CGM) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Continuous Glucose Monitoring (CGM) Sales by Country (2019-2030)
3.5.3 Europe Continuous Glucose Monitoring (CGM) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Continuous Glucose Monitoring (CGM) Market Facts & Figures by Country
3.6.1 Asia Pacific Continuous Glucose Monitoring (CGM) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Continuous Glucose Monitoring (CGM) Sales by Country (2019-2030)
3.6.3 Asia Pacific Continuous Glucose Monitoring (CGM) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Continuous Glucose Monitoring (CGM) Market Facts & Figures by Country
3.7.1 Latin America Continuous Glucose Monitoring (CGM) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Continuous Glucose Monitoring (CGM) Sales by Country (2019-2030)
3.7.3 Latin America Continuous Glucose Monitoring (CGM) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Continuous Glucose Monitoring (CGM) Market Facts & Figures by Country
3.8.1 Middle East and Africa Continuous Glucose Monitoring (CGM) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Continuous Glucose Monitoring (CGM) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Continuous Glucose Monitoring (CGM) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Continuous Glucose Monitoring (CGM) Sales by Type (2019-2030)
4.1.1 Global Continuous Glucose Monitoring (CGM) Sales by Type (2019-2024)
4.1.2 Global Continuous Glucose Monitoring (CGM) Sales by Type (2025-2030)
4.1.3 Global Continuous Glucose Monitoring (CGM) Sales Market Share by Type (2019-2030)
4.2 Global Continuous Glucose Monitoring (CGM) Revenue by Type (2019-2030)
4.2.1 Global Continuous Glucose Monitoring (CGM) Revenue by Type (2019-2024)
4.2.2 Global Continuous Glucose Monitoring (CGM) Revenue by Type (2025-2030)
4.2.3 Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Type (2019-2030)
4.3 Global Continuous Glucose Monitoring (CGM) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Continuous Glucose Monitoring (CGM) Sales by Application (2019-2030)
5.1.1 Global Continuous Glucose Monitoring (CGM) Sales by Application (2019-2024)
5.1.2 Global Continuous Glucose Monitoring (CGM) Sales by Application (2025-2030)
5.1.3 Global Continuous Glucose Monitoring (CGM) Sales Market Share by Application (2019-2030)
5.2 Global Continuous Glucose Monitoring (CGM) Revenue by Application (2019-2030)
5.2.1 Global Continuous Glucose Monitoring (CGM) Revenue by Application (2019-2024)
5.2.2 Global Continuous Glucose Monitoring (CGM) Revenue by Application (2025-2030)
5.2.3 Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Application (2019-2030)
5.3 Global Continuous Glucose Monitoring (CGM) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Continuous Glucose Monitoring (CGM) Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Corporation Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Baxter Continuous Glucose Monitoring (CGM) Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 Abbott Laboratories
6.3.1 Abbott Laboratories Corporation Information
6.3.2 Abbott Laboratories Description and Business Overview
6.3.3 Abbott Laboratories Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Abbott Laboratories Continuous Glucose Monitoring (CGM) Product Portfolio
6.3.5 Abbott Laboratories Recent Developments/Updates
6.4 Medtronic
6.4.1 Medtronic Corporation Information
6.4.2 Medtronic Description and Business Overview
6.4.3 Medtronic Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Medtronic Continuous Glucose Monitoring (CGM) Product Portfolio
6.4.5 Medtronic Recent Developments/Updates
6.5 Animas
6.5.1 Animas Corporation Information
6.5.2 Animas Description and Business Overview
6.5.3 Animas Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Animas Continuous Glucose Monitoring (CGM) Product Portfolio
6.5.5 Animas Recent Developments/Updates
6.6 Novo Nordisk
6.6.1 Novo Nordisk Corporation Information
6.6.2 Novo Nordisk Description and Business Overview
6.6.3 Novo Nordisk Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Novo Nordisk Continuous Glucose Monitoring (CGM) Product Portfolio
6.6.5 Novo Nordisk Recent Developments/Updates
6.7 Ypsomed
6.6.1 Ypsomed Corporation Information
6.6.2 Ypsomed Description and Business Overview
6.6.3 Ypsomed Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ypsomed Continuous Glucose Monitoring (CGM) Product Portfolio
6.7.5 Ypsomed Recent Developments/Updates
6.8 GlySens
6.8.1 GlySens Corporation Information
6.8.2 GlySens Description and Business Overview
6.8.3 GlySens Continuous Glucose Monitoring (CGM) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 GlySens Continuous Glucose Monitoring (CGM) Product Portfolio
6.8.5 GlySens Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Continuous Glucose Monitoring (CGM) Industry Chain Analysis
7.2 Continuous Glucose Monitoring (CGM) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Continuous Glucose Monitoring (CGM) Production Mode & Process
7.4 Continuous Glucose Monitoring (CGM) Sales and Marketing
7.4.1 Continuous Glucose Monitoring (CGM) Sales Channels
7.4.2 Continuous Glucose Monitoring (CGM) Distributors
7.5 Continuous Glucose Monitoring (CGM) Customers
8 Continuous Glucose Monitoring (CGM) Market Dynamics
8.1 Continuous Glucose Monitoring (CGM) Industry Trends
8.2 Continuous Glucose Monitoring (CGM) Market Drivers
8.3 Continuous Glucose Monitoring (CGM) Market Challenges
8.4 Continuous Glucose Monitoring (CGM) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
